These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2090223)

  • 41. Visceral leishmaniasis in HIV-infected patients in the south of France.
    Dereure J; Reynes J; Pratlong F; Lamaury I; Rioux JA; Janbon F; Dedet JP
    Bull World Health Organ; 1995; 73(2):245-6. PubMed ID: 7743597
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in a HIV infected patient with multiple relapsing leishmaniasis from Western Europe.
    Rihl M; Stoll M; Ulbricht K; Bange FC; Schmidt RE
    J Infect; 2006 Jul; 53(1):e25-7. PubMed ID: 16274744
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Allopurinol for treatment of visceral leishmaniasis in patients with AIDS.
    Dellamonica P; Bernard E; Le Fichoux Y; Politano S; Carles M; Durand J; Mondain V
    J Infect Dis; 1989 Nov; 160(5):904-5. PubMed ID: 2809265
    [No Abstract]   [Full Text] [Related]  

  • 44. Allopurinol in the treatment of canine visceral leishmaniasis.
    Liste F; Gascon M
    Vet Rec; 1995 Jul; 137(1):23-4. PubMed ID: 7483228
    [No Abstract]   [Full Text] [Related]  

  • 45. Visceral leishmaniasis in a patient seropositive for HIV.
    Alvar J; Verdejo J; Osuna A; Nájera R
    Eur J Clin Microbiol; 1987 Oct; 6(5):604-6. PubMed ID: 3436325
    [No Abstract]   [Full Text] [Related]  

  • 46. Unusual presentation of visceral leishmaniasis in an HIV-infected patient.
    Cenderello G; Pontali E; Ruggeri C; Dusi A; De Maria A
    AIDS Res Hum Retroviruses; 2014 Sep; 30(9):846-7. PubMed ID: 25054214
    [No Abstract]   [Full Text] [Related]  

  • 47. Use of an Itraconazole/allopurinol combination for the treatment of visceral leishmaniasis in a patient with AIDS.
    Raffi F; Merrien D; Le Pape P; Reliquet V
    Clin Infect Dis; 1995 Nov; 21(5):1338-9. PubMed ID: 8589174
    [No Abstract]   [Full Text] [Related]  

  • 48. Treatment of canine visceral leishmaniasis with allopurinol.
    Vercammen F; De Deken R
    Vet Rec; 1995 Sep; 137(10):252. PubMed ID: 8533220
    [No Abstract]   [Full Text] [Related]  

  • 49. Treatment of visceral leishmaniasis with meglumine and allopurinol.
    Ragusa R; Di Cataldo A; Samperi P; Schiliro G
    Am J Dis Child; 1993 Jun; 147(6):611-2. PubMed ID: 8506827
    [No Abstract]   [Full Text] [Related]  

  • 50. Evaluation of allopurinol in the treatment of kala-azar occurring in North Bihar, India.
    Jha TK
    Trans R Soc Trop Med Hyg; 1983; 77(2):204-7. PubMed ID: 6868102
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Leishmaniasis in a HIV (LAV/HTLV III) serologically positive patient.
    Blázquez J; Alvar J; Nájera R
    J Infect; 1987 Jan; 14(1):89-90. PubMed ID: 3819462
    [No Abstract]   [Full Text] [Related]  

  • 52. Stevens Johnson syndrome in a patient with HIV & visceral leishmaniasis.
    Pandey K; Singh D
    Indian J Med Res; 2013 Sep; 138(3):368-9. PubMed ID: 24135185
    [No Abstract]   [Full Text] [Related]  

  • 53. Frequency of subclinical visceral leishmaniasis in HIV-1-infected patients in Spain.
    Pineda JA; Hernández-Quero J; Gallardo JA; López-Ruz MA; Martínez-Pérez MA; Macías J; Lissen E
    Eur J Clin Microbiol Infect Dis; 1996 Mar; 15(3):263-4. PubMed ID: 8740869
    [No Abstract]   [Full Text] [Related]  

  • 54. Delayed reactivation of visceral leishmaniasis complicating HIV infection.
    Visvanathan K; Jones PD; Riordan SM; Thomas MC
    Aust N Z J Med; 1993 Aug; 23(4):407. PubMed ID: 8240156
    [No Abstract]   [Full Text] [Related]  

  • 55. Visceral leishmaniasis in HIV-infected patients.
    Flegg PJ; Brettle RP
    AIDS; 1990 Apr; 4(4):366-7. PubMed ID: 1972022
    [No Abstract]   [Full Text] [Related]  

  • 56. Specificity of a commercial indirect immunofluorescence technique in the diagnosis of visceral leishmaniasis in patients infected with HIV-1.
    Gallardo JA; Pineda JA; Macías J; Torronteras R; Lissen E
    Trans R Soc Trop Med Hyg; 1996; 90(4):383. PubMed ID: 8882181
    [No Abstract]   [Full Text] [Related]  

  • 57. [Visceral leishmaniasis and peritoneal tuberculosis in a patient with human immunodeficiency virus infection].
    Millán Rodríguez AB; Domínguez-Castellano A; Rodríguez Baño J; Ríos MJ
    Med Clin (Barc); 2003 Sep; 121(9):357-8. PubMed ID: 14499077
    [No Abstract]   [Full Text] [Related]  

  • 58. Latex agglutination test for visceral leishmaniasis.
    Arya SC
    Trans R Soc Trop Med Hyg; 1997; 91(3):366. PubMed ID: 9254461
    [No Abstract]   [Full Text] [Related]  

  • 59. [Lung radiography anomalies in heroin addicts: place of HIV infection].
    Escamilla R; Hermant C; Ortelli C; Krempf M
    Presse Med; 1992 Jan 4-11; 21(1):40. PubMed ID: 1531264
    [No Abstract]   [Full Text] [Related]  

  • 60. Necrotizing glomerulonephritis in patients with HIV, HCV and visceral leishmaniasis.
    Puerta Carretero M; Ortega Díaz M; Corchete Prats E; Roldán Cortés D; Cuevas Tascón G; Martín Navarro JA; Jaldo Rodríguez MT; Medina Zahonero L; Cintra Cabrera M; Ryan Murúa P; Albalate Ramón M; de Sequera Ortiz P; Alcázar Arroyo R
    Nefrologia (Engl Ed); 2020; 40(4):481-484. PubMed ID: 31551119
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.